Viewing Study NCT03161093


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-03-02 @ 4:12 AM
Study NCT ID: NCT03161093
Status: COMPLETED
Last Update Posted: 2022-11-14
First Post: 2017-05-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
Sponsor: Regeneron Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: R475-OA-1611
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View